Apotex will aim to leverage the synergies between itself and Searchlight Pharma to “accelerate our continued growth,” after quickly closing its acquisition of its fellow Canadian firm.
Traditional generics and biosimilars firm Apotex has accelerated its growth within the specialty innovative branded pharmaceutical space, after quickly wrapping up its acquisition of fellow private Canadian company Searchlight Pharma.
Announced at the beginning of April (see sidebar), the deal was characterized by Apotex as creating a “Canadian health champion...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
